Citigroup
WVE icon

Citigroup’s Wave Life Sciences WVE Stock Holding History

Citigroup’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,000
Closed -$850K – 6449
2025
Q4 		$850K Buy
+50,000
New +$508K ﹤0.01% 3236

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Citigroup's WVE Position: Q2 2026 in Review

Citigroup reduced its Wave Life Sciences (WVE) stake by 75% in Q2 2026, selling an estimated $2.5M and leaving 125,051 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Citigroup first reported a position in WVE in Q4 2015 and has held it in 42 quarters since. The position peaked at $3.64M in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Citigroup held 125,051 shares of Wave Life Sciences worth $727K as of Q2 2026.
  • Citigroup sold 376,426 Wave Life Sciences shares in Q2 2026, an estimated $2.5M.
  • Wave Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3677 holding.
  • Citigroup first reported a position in Wave Life Sciences in Q4 2015 and has held it in 42 quarters since.
  • Citigroup's Wave Life Sciences position peaked at $3.64M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.